bottom line report revenu line ep slightli
cs/street guid due divestitur semiconductor
cryogen busi announc august acquisit
semi shipment tier oem consist lower front-end process tool
shipment inventori burn guid decemb flat march
life scienc compani guid incorpor partial genewiz
manag continu see higher compound-annual-growth-rate semi compani
expect see signific perturb rev ep next qs
due divestitur acquisit expect genewiz off-set
revenu impact cryo rev ep north
adjust ep
street current lower pt ep
current trade ntm w/sbc vs klac/lrcx despit
lower opm view valuat fair risk tp includ
macro uncertainti lower wfe delay acquisit contribut would
highlight follow
line/ep slightli street
street ep slightli result
reflect impact cryo divestitur semi segment declin
q/q ex cryo impact life scienc q/q
rev/ep guidanc cs street rev/ep
street due impact cryo divestitur
remain semi flattish partial genewiz
price-to-earnings valuat seem fair current trade price-to-earnings roughli
turn premium front end peer expect life
scienc busi continu perform well acquisit contribut
leverag growth
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price rate neutral target price analyst john pitzer
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ activ
effect exchang rate
chang net cash/debt
net debt end
total liabil equiti
share wtd average
blue sky scenario compani earn ep
istock could worth base ep
grey sky scenario compani revenu declin
semi grow lifesci growth expect
scenario compani stock could worth base
ep
inc brook provid autom
vacuum instrument solut busi partner
origin equip manufactur oem equip user
 close
charl martineau pm univers toronto summari result expect
figur summari result expect
us million unless otherwis state
inclus cryogen q/q mostli in-line cs
q/q street q/q guidanc
q/q midpoint q/q semi solut q/q
in-line cs estim q/q life scienc
q/q in-line cs estim q/q compani note semi
declin led vacuum autom growth life scienc driven
sampl storag grew ex-cryogen y/i vs y/i
y/i
gm opex gm bp q/q cs estim
bp q/q semi solut busi non-gaap gm
bp q/q driven improv margin solut new
design win life scienc non-gaap gm bp q/q
due higher cost store system headwind realloc expens
discontinu busi non-gaap opex
cs
strength semi solut semi solut declin q/q
y/i vacuum autom sequenti septemb
tier oem shipment declin slow demand howev segment
fiscal year advanc packag revenu
contamin control solut sequenti compani
expect growth decemb compani expect see build-out
modest growth lifesci life scienc grew sequenti y/i
organ sampl storag busi grew y/i autom store
system declin full year compani
receiv order cryostorag system key custom shipment
ep slightli cs/street interest expens q/q
cs estim incom tax q/q
cs estim opm q/q cs
estim bp q/q street estim bp q/q
despit lower expect opm lower tax expens higher gm drove ep
in-line cs estim street well guidanc
midpoint
decq cs/street ep in-line street guid
ex-cryogen q/q q/q midpoint
q/q cs q/q street q/q
estim inclus inclus revenu exclus genewiz
note septemb decemb qs would bottom
busi march dec also see half quarter
genewiz revenu manag expect see revenu ep
perturb next qs effect divestitur acquisit flow
 ep ex-cryogen guid mid-point
cs estim w/
semi solut flattish dec forecast semi solut busi
flattish q/q decemb vs compani see sign
expans march express confid full year
cryogen busi replac faster-grow genewiz life
scienc busi genewiz return growth semi fulli
off-set impact cryo
growth opportun remain life scienc close genewiz
acquisit novemb guid revenu decemb
full year compani expect see growth exist life scienc
busi genewiz suggest total life scienc revenu
compani partial financ genewiz acquisit debt
paid cryo divestitur goe
meantim compani interest expens per fall
follow paydown debt
figur incom statement summari thousand
compani mention price
